Kristen Laguerre is a seasoned operating executive and Managing Director at MPM BioImpact, specializing in the field of venture capital. With over 20 years of financial leadership, Kristen plays a key role in overseeing the finance, operations, and administrative functions at MPM BioImpact. She is also an investment committee member of the Oncology Impact Funds, contributing to advancements in the field of cancer vaccines and new modalities. Kristen's notable experience includes her role as interim CFO at ReNAgade Therapeutics and her prior position as CFO at Cullinan Oncology, underscoring her commitment to driving progress in cancer-related ventures.